| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-10 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-10 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-10 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-10 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-10 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-09 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-09 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-09 |